Search
Close this search box.

NIIMBL Is Now Accepting Applications for the 2024 NIIMBL eXperience Cohort

Newark, Del., October 17, 2023 – The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has awarded approximately $500k in funding to launch the 2024 NIIMBL eXperience program in five locations across the United States. The application period is now open for the following locations: Albany College of Pharmacy and Health Sciences (ACPHS)- New York, Biomanufacturing Training Center at North Carolina State University, Thomas Jefferson University- Pennsylvania, Santa Clara University- California, and the…

NIIMBL Launches Viral Vector Program to Improve Access to AAV Gene Therapy

NEWARK, Del., October 10, 2023 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) officially launches the Viral Vectors NIIMBL-led Program focused on developing and making broadly available robust, economically viable, shared manufacturing process and analytical platforms for Adeno-Associated Virus (AAV) gene therapy vectors. NIIMBL has committed to this effort with an ultimate vision to provide access to high quality viral vectors capable of serving the full spectrum of patient need, from prevalent indications to ultra-rare diseases, without cost or…

NIIMBL awards $370K for 5 eXperience programs in 2024

NIIMBL is pleased to announce it has awarded $370K to launch five NIIMBL eXperience programs next summer. These host locations represent distinct regions across the country. Each location will host a week-long program, designed to introduce Black, Latinx, and Indigenous college students to career possibilities in the biopharmaceutical industry. The 2024 NIIMBL eXperience host locations are…

NIIMBL Announces RFI for Next-Generation Sequencing Method Development Study

NEWARK, Del., August 10, 2023 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce a Request for Information (RFI) related to a planned method development study, focused on the development and optimization of Next-Generation Sequencing (NGS) methods for extended characterization of Adeno-Associated Virus (AAV) gene therapy…

NIIMBL Announces New Funding Opportunities

Featured News PC7p1_experienceRFA 2023 jpg

NEWARK, Del., June 8, 2023 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $4M in funding through Project Call (PC) 7.1 and an additional $500k in funding for prospective regional leads for the 2024 NIIMBL eXperience Program. The PC7.1 Request for Proposals (RFP) and the 2024 NIIMBL eXperience Requests for Applications (RFA)…

NIIMBL Selects Largest eXperience Program Cohort to Date

Featured Event Experience 2023

Newark, Del., April 25, 2023 – The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has announced the selection of 44 college freshman and sophomores to participate in the 2023 NIIMBL eXperience Program, the largest cohort to date since the program launched in 2019. Students were selected from 34 educational institutions across the United States to attend one of three cohorts hosted at Albany College of Pharmacy and Health Sciences (ACPHS) in New York, Kansas Bioscience Association (BioKansas) in the Kansas/Missouri Region, and Raritan Valley Community College in New Jersey. The program aims to introduce Black, Latinx, and Indigenous students to the biopharmaceutical manufacturing industry to ultimately increase the diversity of the school-to-industry pipeline and to build a workforce…

NIIMBL Addresses Talent Pipeline Through Industry and Comm College Collaboration

Featured News Workforce Whitepaper2 jpg

NEWARK, Del., March 28, 2023 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) issues Part II of a whitepaper series titled Innovation of the Biopharmaceutical Manufacturing Talent Pipeline, a series focused on highlighting non-traditional and novel solutions for the talent pipeline gap in the biopharmaceutical industry. The newest whitepaper focuses on successes and challenges faced by community college biotechnology degree programs and makes the case for stronger engagement between…

NIIMBL Announces $1.7M for 3 New Vaccine Manufacturing Projects

Vaccine Events Preview jpg

NEWARK, Del., February 28, 2023 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $1.7M in planned project activities through the Institute’s Global Health Fund (GHF) Project Call 6.1G for three new projects focused on the development of in vitro potency assays for vaccines being produced by mRNA and/or viral vector…

NIIMBL Announces First Faculty Fellows Program Recipient: Dr. Sarah W. Harcum

Sarah Harcum FeaturedNews jpg

Newark, Del., December 20, 2022 — Today, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announces the first recipient of the new Faculty Fellows Program, Dr. Sarah W. Harcum of Clemson University. The NIIMBL Faculty Fellows Program is a pilot program that provides financial support for faculty and instructional staff at universities and community colleges to pursue a sabbatical with NIIMBL industry member organizations or…

NIIMBL Awards over $200k to Expand eXperience Program

Featured Event Experience 2023

Newark, Del., November 15, 2022 – The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has awarded over $200k in funding to launch the 2023 NIIMBL eXperience program in three distinct locations across the United States. Funding recipients include Albany College (ACPHS) in New York, BioKansas in the Kansas/Missouri Region, and Raritan Valley Community College in…

NIIMBL Pilots Biopharma Manufacturing Program to High School Students in NC

Featured News NIMBL biologic jpg

NEWARK, Del., October 25, 2022 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) launches NIIMBL bioLOGIC, a pilot program designed to bring awareness to and foster interest in careers in the biopharmaceutical manufacturing industry. NIIMBL has partnered with the North Carolina Biotechnology Center and has selected Southern High School of Energy and Sustainability to pilot the 5-week program where students not only will learn and innovate but also will visualize themselves with a career in…

NIIMBL and BioPhorum Announce Buffer Skid Data and Design for Open Access

Featured News BRLs2 jpg

NEWARK, Del., October 18, 2022 — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) in collaboration with BioPhorum is pleased to announce that the data and design specification for the NIIMBL BioPhorum Buffer Stock Blending System are now publicly available for open-source use. This new current good manufacturing practices (cGMP) buffer technology is designed, built, and tested to deliver buffer on-demand on a commercial at significant cost savings in labor and cost per liter compared to traditional…

Join Our Mailing List

MailChimp NIIMBL Mailing List Signup
Organization Type
How did you first hear about NIIMBL?